We integrate innovative biochemical markers with subject recruitment and centralized medical image analysis to efficiently drive development.
Let our biochemical-marker expertise minimize the time, number of subjects, and financial resources necessary for your next clinical study.
We strive to develop biochemical markers that can serve as surrogates for key outcome parameters, such as fracture risk, survival, and quality of life. Our in house scientific experts help SYNARC clients select the most appropriate biochemical markers for each clinical trial.
Our services combine biochemical markers and imaging results to predict disease progression in a timely and accurate way. We limit measurement variability through our comprehensive and strict quality control program, and we support our clients’ clinical sites with all the resources needed for success.
Our unique biochemical-marker services provide more accurate and precise assessment of efficacy and greater statistical power, which support better-informed and earlier decisions about the course of a clinical trial.
CCBR-SYNARC’s centralized oversight of biochemical-marker studies ensures accurate, rapid, and standardized collection and review of clinical data by our expert medical and scientific staff. Global data management is customized and fully regulatory compliant.
Link to SYNARC biochemical-markers
Working with CCBR speeds up and drives efficiencies in clinical trials by offering greater numbers of patients across fewer sites
A Global Footprint covering more than 20 dedicated Clinical Research Centers in high density population areas
Uniform SOPs enable the tightest possible adherence to study protocols and consistency across all CCBR sites
Real-Time tacking of subject enrolment and trial progress ensures sponsors have the most up to date information, all of the time
Centralised, standardised billing affords better visibility into trial costs for sponsors
